![Curtis Patton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Curtis Patton
Geen lopende functies
Vermogen: 172 375 $ op 31-05-2026
Profiel
Curtis Patton is currently an Independent Director at Tevogen Bio Holdings, Inc. since 2024 and a Professor-Emeritus at Yale School of Public Health.
Formerly, Dr. Patton was a Director at Tevogen Bio, Inc. and Head of Global Health at Yale University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,52% | 28-04-2026 | 21.792 ( 0,52% ) | 172 375 $ | 31-05-2026 |
Actieve functies van Curtis Patton
| Bedrijven | Functie | Begin |
|---|---|---|
Yale School of Public Health
 Yale School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Eerdere bekende functies van Curtis Patton
| Bedrijven | Functie | Einde |
|---|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Tevogen Bio, Inc.
 Tevogen Bio, Inc. BiotechnologyHealth Technology Develops investigational therapies to treat viral infections | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
1
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Public Health
Yale School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tevogen Bio, Inc.
Tevogen Bio, Inc. BiotechnologyHealth Technology Develops investigational therapies to treat viral infections | Health Technology |
